Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN950689 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-BTG Family, Member 3 (BTG3) (AA 107-137), (Middle Region) antibody
- Antibody type
- Polyclonal
- Description
- Affinity chromatography on Protein A
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 107-137, Middle Region
- Vial size
- 0.4 mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer.
Methylation-mediated downregulation of the B-cell translocation gene 3 (BTG3) in breast cancer cells.
The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1.
The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease.
Association of ANA, a member of the antiproliferative Tob family proteins, with a Caf1 component of the CCR4 transcriptional regulatory complex.
Majid S, Dar AA, Ahmad AE, Hirata H, Kawakami K, Shahryari V, Saini S, Tanaka Y, Dahiya AV, Khatri G, Dahiya R
Carcinogenesis 2009 Apr;30(4):662-70
Carcinogenesis 2009 Apr;30(4):662-70
Methylation-mediated downregulation of the B-cell translocation gene 3 (BTG3) in breast cancer cells.
Yu J, Zhang Y, Qi Z, Kurtycz D, Vacano G, Patterson D
Gene expression 2008;14(3):173-82
Gene expression 2008;14(3):173-82
The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1.
Ou YH, Chung PH, Hsu FF, Sun TP, Chang WY, Shieh SY
The EMBO journal 2007 Sep 5;26(17):3968-80
The EMBO journal 2007 Sep 5;26(17):3968-80
The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease.
Kiechl S, Werner P, Knoflach M, Furtner M, Willeit J, Schett G
Expert review of cardiovascular therapy 2006 Nov;4(6):801-11
Expert review of cardiovascular therapy 2006 Nov;4(6):801-11
Association of ANA, a member of the antiproliferative Tob family proteins, with a Caf1 component of the CCR4 transcriptional regulatory complex.
Yoshida Y, Hosoda E, Nakamura T, Yamamoto T
Japanese journal of cancer research : Gann 2001 Jun;92(6):592-6
Japanese journal of cancer research : Gann 2001 Jun;92(6):592-6
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
